Richard Faragher
Sectors: Longevity Legends, Science and Academia.
Richard Faragher is Professor of Biological Gerontology at the University of Brighton and past Chair of the British Society for Research on Ageing, the International Association of Biomedical Gerontology and the American Aging Association. His primary research interest is the relationship between cellular senescence and organismal ageing. In 2002 his work on the accelerated ageing disease Werner’s syndrome led to the award of the Royal Pharmaceutical Society Conference Science Medal for outstanding scientific achievement. In 2005 he became the first ever scientist to receive a Help the Aged award for my championship of older people and the use of research for their benefit.
In 2010, he became the first ever British recipient of the Paul F Glenn Award for research into the biological mechanisms of the ageing process. He is a visiting Professor at the Moscow Institute of Physics and Technology and a Trustee of the Biogerontology Research Foundation. He has served as a member of the Research Advisory Council of the Charity Research into Ageing and on strategy and funding panels for the BBSRC, the US National Institutes on Ageing and the European Union. From 2005-2008 he was Co-director of the BBSRC-EPSRC SPARC programme, a research network designed to build national capacity to conduct inter-disciplinary ageing research. In 2015 he became the first British citizen to be elected to the Board of Directors of the American Federation for Aging Research, the leading US non-profit organization supporting and advancing healthy aging through biomedical research. In 2016 he was presented with the highest award for services to gerontology in the United Kingdom, the Lord Cohen of Birkenhead Medal and became a Fellow of the American Aging Association.
Richard Faragher is Professor of Biological Gerontology at the University of Brighton and past Chair of the British Society for Research on Ageing, the International Association of Biomedical Gerontology and the American Aging Association. His primary research interest is the relationship between cellular senescence and organismal ageing. In 2002 his work on the accelerated ageing disease Werner’s syndrome led to the award of the Royal Pharmaceutical Society Conference Science Medal for outstanding scientific achievement. In 2005 he became the first ever scientist to receive a Help the Aged award for my championship of older people and the use of research for their benefit.
In 2010, he became the first ever British recipient of the Paul F Glenn Award for research into the biological mechanisms of the ageing process. He is a visiting Professor at the Moscow Institute of Physics and Technology and a Trustee of the Biogerontology Research Foundation. He has served as a member of the Research Advisory Council of the Charity Research into Ageing and on strategy and funding panels for the BBSRC, the US National Institutes on Ageing and the European Union. From 2005-2008 he was Co-director of the BBSRC-EPSRC SPARC programme, a research network designed to build national capacity to conduct inter-disciplinary ageing research. In 2015 he became the first British citizen to be elected to the Board of Directors of the American Federation for Aging Research, the leading US non-profit organization supporting and advancing healthy aging through biomedical research. In 2016 he was presented with the highest award for services to gerontology in the United Kingdom, the Lord Cohen of Birkenhead Medal and became a Fellow of the American Aging Association.